Dietary mutagens and the risk of breast cancer.

lar genetic mechanisms. Nephrol Dial Transplant 1996;11 Suppl 6:34–7. (10) Thoenes W, Storkel S, Rumpelt HJ, Moll R. Cytomorphological typing of renal cell carcinoma—a new approach. Eur Urol 1990;18 (Suppl 2):6–9. (11) Gnarra JR, Duan DR, Weng Y, Humphrey JS, Chen DY, Lee S, et al. Molecular cloning of the von Hippel–Lindau tumor suppressor gene and its role in renal carcinoma. Biochim Biophys Acta 1996;1242:201–10. (12) Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P, et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 1997;16: 68–73. (13) Shiao YH, Rice JM, Anderson LM, Diwan BA, Hard GC. von Hippel– Lindau gene mutations in N-nitrosodimethylamine-induced rat renal epithelial tumors. J Natl Cancer Inst 1998;90:1720–3. (14) Shiao YH, Diwan BA, Perantoni AO, Calvert RJ, Zbar B, Lerman MI, et al. Polymerase chain reaction-single-strand conformation polymorphism analysis for the VHL gene in chemically induced kidney tumors of rats using intron-derived primers. Mol Carcinog 1997;19:230–5. (15) Kikuchi Y, Kobayashi E, Nishizawa M, Hamazaki S, Okada S, Hino O. Cloning of the rat homologue of the von Hippel-Lindau tumor suppressor gene and its non-somatic mutation in rat renal cell carcinomas. Jpn J Cancer Res 1995;86:905–9. (16) Staley JP, Guthrie C. Mechanical devices of the spliceosome: motors, clocks, springs, and things. Cell 1998;92:315–26. (17) Walker C. Molecular genetics of renal carcinogenesis. Toxicol Pathol 1998;26;113–20. (18) Kao-Shan CS, Fine RL, Whang-Peng J, Lee EC, Chabner BA. Increased fragile sites and sister chromatid exchanges in bone marrow and peripheral blood of young cigarette smokers. Cancer Res 1987;47:6278–82. (19) Sekido Y, Bader S, Latif F, Gnarra JR, Gazdar AF, Linehan WM, et al. Molecular analysis of the von Hippel–Lindau disease tumor suppressor gene in human lung cancer cell lines. Oncogene 1994;9:1599–604.